Table 2.

Site of Surgical Resection by Response to Checkpoint Inhibitor Therapy at Time of Initial Operation (N=237)

Site of Initial Operation (N=237)	N (%)	Group 1 (N=12)	Group 2 (N=106)	Group 3 (N=119)
All Patients	237 (100)	12 (5)	106 (45)	119 (50)
Skin/Soft Tissue	72 (30)	3 (25)	29 (27)	40 (34)
Lymph Nodes	42 (18)	5 (42)	30 (28)	7 (6)
Lung	11 (5)	2 (17)	9 (8)	0
Liver	3 (1)	0 (0)	3 (3)	0
Other Abdominal Disease	42 (18)	1 (8)	25 (24)	16 (13)
Bone	4 (1.5)	0 (0)	2 (2)	2 (2)
Brain/CNS	63 (26.5)	1 (8)	8 (8)	54 (45)